Paris Panayiotopoulos, Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 28,570 shares at $7.03 ($201K) on 2017-11-16, disclosed to the SEC on 2017-11-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.03 | 14,285 | $100K | 50.0% |
| 2 | $7.03 | 14,285 | $100K | 50.0% |
| Total | $7.03 avg | 28,570 | $201K | 100% |
| Filing → |
| ARIA | BUY | 2016-02-03 | $600K | — | Filing → |